Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast agent presented as a solution for injection for intra‑arterial and intravenous use. It enhances X‑ray attenuation, allowing clearer visualization of vascular structures and organs during diagnostic imaging procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron, an iodinated contrast agent, is used in diagnostic imaging to improve X‑ray attenuation of vascular and organ structures.

- Angiography: provides enhanced visualization of blood vessels during catheter‑based studies. - Computed tomography (CT) imaging: increases contrast between tissues, aiding detection of lesions and anatomical detail. - Vascular imaging: highlights arterial and venous pathways for accurate assessment of circulatory disorders.

Iomeron may cause a range of reactions, most of which are mild and transient.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste in the mouth. - Mild nausea or vomiting. - Headache. - Transient itching or skin rash.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Thyroid dysfunction due to iodine load. - Cardiac arrhythmias or arrest. - Seizures. - Pulmonary edema.

Prior to using Iomeron, clinicians should evaluate patient‑specific risk factors and follow safe handling practices.

- Renal function assessment: verify adequate kidney function before administration. - Iodine allergy history: screen for previous reactions to iodinated contrast. - Use lowest effective dose: limit exposure while achieving diagnostic quality. - Monitor thyroid status: consider in patients with thyroid disease. - Avoid in severe dehydration: ensure proper hydration before the procedure. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Iomeron can interact with other agents that affect renal function or iodine metabolism.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents. - High‑dose iodine supplements or thyroid hormone therapy. - Nephrotoxic drugs such as aminoglycosides or high‑dose NSAIDs.

Moderate Interactions (Monitor Closely): - Diuretics that may alter fluid balance. - ACE inhibitors or ARBs, which can affect renal perfusion. - Metformin, due to risk of lactic acidosis in renal impairment. - Beta‑blockers, which may mask contrast‑induced hypertension. - Thyroid medications, requiring monitoring of thyroid function tests.